Search Results 1361-1370 of 74755 for Molecular
— Mayo Clinic researchers have identified a new set of molecular markers in blood plasma. This discovery could lead to the development of improved ...
Further development of these polypeptide and small-molecule inhibitors for enhanced mesotrypsin selectivity may generate targeted therapeutics that can reduce ...
In addition, she works with colleagues specializing in endocrinology to investigate the molecular mechanisms of skeletal muscle atrophy, a poorly understood ...
After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may ...
Study shows immune molecule may play key role in the progression ... Researchers discover new molecular drug targets for progressive neurological disorder.
... Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health. More about research at Mayo Clinic. Research Faculty · Laboratories ...
Emeritus, Department of Molecular Pharmacology and Experimental Therapeutics. Academic Rank. Professor of Biophysics; Professor of Pharmacology. EDUCATION.
The molecule NAD is a potential target for novel cancer therapy for several types of cancers, including the deadly pancreatic cancer. Polycystic kidney disease.
Lucien-Matteoni's research covers multiple disciplines including molecular and cellular biology, cancer immunology, tumor metabolism, human-subject research, ...
The Lymph3Cx test was validated in the Mayo Clinic Molecular Diagnostics – Arizona Laboratory and uses routinely available pathological specimens. The ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.